Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities. May–September 2010
To quantify the magnitude of healthcare-associated infections in long-term care facilities at the European level, ECDC provided funding for the Healthcare-Associated infections in Long-Term care facilities (HALT) project, which developed a sustainable methodology based on a repeated Point Prevalence Survey design to study their prevalence and to explore related infection prevention and control structures and process indicators in the same group of facilities.
The first survey was organised between May to September 2010, and this report documents its findings.
Antimicrobial consumption in the EU/EEA (ESAC-Net) - Annual Epidemiological Report for 2020
18 Nov 2021 - For 2020, twenty-nine countries (27 European Union (EU) Member States and two European Economic Area (EEA) countries - Iceland and Norway) reported data on antimicrobial consumption. Twenty-five countries reported data for both community and hospital consumption; two countries (Germany and Iceland) reported only community consumption, and two countries (Cyprus and Czechia) reported total consumption for both sectors combined.
JIACRA III - Antimicrobial consumption and resistance in bacteria from humans and animals
30 Jun 2021 - Third joint inter-agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU/EEA.
Antimicrobial consumption - Annual Epidemiological Report for 2019
18 Nov 2020 - In 2019, the average total (community and hospital sector combined) consumption of antibacterials for systemic use (Anatomical Therapeutic Chemical (ATC) group J01) in the EU/EEA was 19.4 defined daily doses (DDD) per 1 000 inhabitants per day (country range: 9.5–34.1). During the period 2010–2019, a statistically significant decrease was observed for the EU/EEA overall.